Navigation Links
Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
Date:2/29/2008

hich speak only as of their dates. These forward- looking statements are based on estimates and assumptions by our management that, although we believe to be reasonable, are inherently uncertain and subject to a number of risks and uncertainties.

The following represent some, but not necessarily all, of the factors that could cause actual results to differ from historical results or those anticipated or predicted by our forward-looking statements: our substantial indebtedness; competitive factors in the industry in which we operate (including the approval and introduction of generic or branded products that compete with our products); our ability to protect our intellectual property; a delay in qualifying our manufacturing facility to produce our products or production or regulatory problems with either third party manufacturers upon whom we may rely for some of our products or our own manufacturing facility; pricing pressures from reimbursement policies of private managed care organizations and other third party payors, government sponsored health systems, the continued consolidation of the distribution network through which we sell our products, including wholesale drug distributors and the growth of large retail drug store chains; the loss of key senior management or scientific staff; adverse outcomes in our outstanding litigation or an increase in the number of litigation matters to which we are subject; government regulation affecting the development, manufacture, marketing and sale of pharmaceutical products, including our ability and the ability of companies with whom we do business to obtain necessary regulatory approvals; our ability to manage the growth of our business by successfully identifying, developing, acquiring or licensing new products at favorable prices and marketing such new products; our ability to obtain regulatory approval and customer acceptance of new products, and continued customer acceptance of our existing products; changes in t
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
2. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
3. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2007 Financial Results
4. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
5. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
6. Cepheid Reports Fourth Quarter and Full Year 2007 Results
7. Strategic Diagnostics Reports Fourth Quarter and Full-Year Financial Results
8. US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results
9. Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter
10. Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results
11. eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...es embedded with a telescope,promise to make it ea...do,other activities requiring sharper distance vis...scribe the advantages of these innovative glasses,...e May/June issue of,Journal of Biomedical Optics, ..."This new design has several advantages," says the...
(Date:7/24/2008)...ll/ -- American Oriental,Bioengineering, Inc. (NYS...,second quarter 2008 financial results on Monday, ...mpany will hold a conference call at 5:00 pm ET on...ter 2008 results. Listeners may,access the call by...rnational callers, access code: 41757592. A webcas...
(Date:7/24/2008).../- Poniard,Pharmaceuticals,...y focused,on oncology, today announced that it wil...second quarter results and provide a corporate upd...nt plan for picoplatin, the,Company,s lead product...ef,executive officer, Ronald A. Martell, president...
(Date:7/24/2008).../ -- Sagent Pharmaceuticals, Inc.,a privately-hel...d that it,has launched ceftazidime for injection, ...ntibiotic. Sagent will offer ceftazidime in 1,and ...vials. According to,IMS data, 2007 sales of inject...ately $45.7 million., "Sagent is proud to be prov...
Breaking Biology Technology:Telescope Embedded in Spectacle Lens Promises to Make Driving Easier for Visually Impaired 2Telescope Embedded in Spectacle Lens Promises to Make Driving Easier for Visually Impaired 3Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31 2Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP 2
...WR , ECL™ Semi-dry Blotters are desi...er results using low current and voltage with a mi...s available with and without built-in power suppli... Complete, uniform electrotransfer of proteins f... • Minimal buffer use—just enough...
...phopeptide • two-dimensional liquid chromatog...ull; reversed-phase chromatography (RPC) • st...inear ion trap mass spectrometer, , ... phospho-peptides in mouse brain tissue. The tryps...exchange chromatography (SCX), followed by reverse...
...onucleus assays • toxicology • image ana...icronucleus induction is a key characteristic of g...mation resulting from DNA strand breakage (clastog...aneugens) is an important component of toxicology ...f micronucleus assays is time consuming and subjec...
...nalyzer • apoptosis • multiplexing ...tosis represents a gene-directed, morphologically ... death. Inappropriate control of apoptosis is asso...ncer, AIDS, neurodegenerative diseases, and ischae...optosis is extremely important when considering th...
Other Biology Technology:ECL Semi-dry Blotters 22D-LC analysis of phosphopeptides in brain tissue using Ettan MDLC and Finnigan LTQ 22D-LC analysis of phosphopeptides in brain tissue using Ettan MDLC and Finnigan LTQ 32D-LC analysis of phosphopeptides in brain tissue using Ettan MDLC and Finnigan LTQ 42D-LC analysis of phosphopeptides in brain tissue using Ettan MDLC and Finnigan LTQ 52D-LC analysis of phosphopeptides in brain tissue using Ettan MDLC and Finnigan LTQ 6Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 2Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 3Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 4Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 5The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 2The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 3The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 4The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 5The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 6The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 7
(Date:7/24/2008)... study by researchers from Columbia University,s M...e most challenging issues in infant health and pre...ountries. In these settings, HIV-infected mothers...eir infants, they should exclusively breast-feed, ...er birth. But according to the study conducted in ...
(Date:7/24/2008)..., 2008 In the life of a cell, the response to DNA...use and repair itself, commit suicide, or grow unc...tudy, published in the July 25th issue of Cell , ...tified a way that cells respond to DNA damage thro...The finding points to a new pathway for the develo...
(Date:7/24/2008)...UL (July 24, 2008) A multi-institutional team of ...y of Minnesota Medical School, have developed a po... robust method will allow researchers to generate ...NA sequences for inactivation or repair. , The po...h.D., director of the Arnold and Mabel Beckman Cen...
(Date:7/24/2008)..., Iowa The University of Iowa and Iowa State Univ...y enhance both institutions, genetic research capa...ased a massively parallel DNA sequencer an instru...ate of millions to billions of bases in a single r... will be available on a fee-for-service basis to r...
Breaking Biology News(10 mins):Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3A new cellular pathway linked to cancer is identified by NYU researchers 2Consortium develops new method to manipulate genetic material 2UI and ISU establish shared DNA sequencing instrumentation 2UI and ISU establish shared DNA sequencing instrumentation 3Charles S Cohen Pacific Design Center Augment Their Support for AIDS Walk Los Angeles 3951 1Charles S Cohen Pacific Design Center Augment Their Support for AIDS Walk Los Angeles 3951 2Charles S Cohen Pacific Design Center Augment Their Support for AIDS Walk Los Angeles 3951 3TopSpin Medical Appoints Cindy Setum Ph D Vice President Clinical Affairs 1321 1TopSpin Medical Appoints Cindy Setum Ph D Vice President Clinical Affairs 1321 29 Wiley authors win Nobel Prizes 3949 19 Wiley authors win Nobel Prizes 3949 2PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 3947 1PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 3947 2PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 3947 3PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 3947 4PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 3947 5PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 3947 6
...y (NYUCD) research team has found the first oral b...rn Homo sapiens out of Africa to Asia. , The te... and comprehensive care at NYUCD, discovered that ...dental caries, has evolved along with its human ho...ingle common ancestor who lived in Africa between ...
...ve care unit (ICU) already are seriously ill, so t...tunately, statistics show that as many as 25 perce...on ventilators develop pneumonia, which can be fat...ause of infection in the hospital, and studies hav...ts and double the length of stay of the patient in...
...learn skills from each other, in the same manner a...mbridge researcher. , Dr Antonio Moura, a Brazilia...hropology, has discovered signs that Capuchin monk...o ward off potential predators. , While not co...evidence that suggests other species have somethin...
...l fuel air pollution in the United States by analy...nwide. , This novel way to measure carbon dioxid...ll help atmospheric scientists better understand w...es in the air. Tracking fossil-fuel-emitted carbon... the world adhere to the Kyoto Protocol, an agreem...
Other Biology News:'Ancestral eve' was mother of all tooth decay 2Bacteria from patient's dental plaque causes ventilator-associated pneumonia 2New evidence of 'human' culture among primates 2New evidence of 'human' culture among primates 3Scientists map air pollution using corn grown in US fields 2
siTrio siRNA --- a cocktail of 3 siRNAs specifically targeted to your target gene of interestis our most popular product. The siTrio reagent guarantees you get more than 75% knockdown of your target
...eaction module is used for nucleic acid amplificat...erchangeable 96-well reaction module (15-100 micro...ules for real-time PCR and features temperature mo...mple probe. It includes the iCycler base with 96 x...
... stackable multi-function incubator. It uses a mic... to accurately control temperature and agitation s...temperature in the incubator. Temperature can be e...r. Built in maintenance-free stepping motor for hy...
Anti Autotaxin /ENPP2 , - (Rabbit)
Biology Products: